Shizuoka, Japan

Yukiko Nishida

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 10.0

ph-index = 2

Forward Citations = 131(Granted Patents)


Company Filing History:


Years Active: 2016-2019

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):

Title: The Innovative Contributions of Yukiko Nishida

Introduction

Yukiko Nishida is a prominent inventor based in Shizuoka, Japan. She has made significant contributions to the field of biomedicine, particularly in the development of bispecific antibodies. With a total of 2 patents, her work has the potential to impact treatments for blood coagulation disorders.

Latest Patents

Nishida's latest patents focus on methods of treatment that involve the administration of bispecific antibodies. These antibodies specifically bind to both blood coagulation factor IX/activated blood coagulation factor IX and blood coagulation factor X. They functionally substitute for the cofactor function of blood coagulation factor VIII, promoting the activation of blood coagulation factor X by activated blood coagulation factor IX. From these antibodies, multispecific antigen-binding molecules with a high activity of functionally substituting for blood coagulation factor VIII have been successfully discovered.

Career Highlights

Yukiko Nishida is currently associated with Chugai Seiyaku Kabushiki Kaisha, a leading pharmaceutical company in Japan. Her innovative research and development efforts have positioned her as a key figure in her field.

Collaborations

Nishida has collaborated with notable colleagues, including Tomoyuki Igawa and Zenjiro Sampei, to advance her research and enhance the impact of her inventions.

Conclusion

Yukiko Nishida's contributions to the field of biomedicine through her innovative patents and collaborations highlight her role as a leading inventor. Her work continues to pave the way for advancements in treatment methodologies for blood coagulation disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…